Beren
110 employees on LinkedIn · 5 known investors
Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems. It focuses on advancing biology and chemistry to address the root causes of diseases.
Founders & leadership
JC

AO

Aaron OndreyinChief Financial Officer
AG

Alex GoldinChief Medical Officer
JS

Jennifer SpinellainChief Regulatory Officer & Head of Quality
IV

Irene von HennigsinSVP, Global Medical Affairs
BS

Bennett SmithinSVP, Commercial
RS

Rajinder SinghinChief Scientific Officer
MH

Magali HickeyinSVP, Technical Operations and CMC
HM

Heather McCueninChief People Officer
PC_B%26W%20(1).jpg)
_B%26W%20(1).jpg)
Peter CicalainGeneral Counsel and Head of Intellectual Property and Innovation
Investors · 5
Competitors · 1
by search overlapCompanies competing with Beren for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Beren do?
- Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems. It focuses on advancing biology and chemistry to address the root causes of diseases.
- Who founded Beren?
- Beren was founded by Jason Camm.
- Who are Beren's investors?
- Beren's investors include Alpha Wave Global, Eisai Innovation, Inc., Narya Capital, Octave Ventures Llc, UTokyo Innovation Platform Co. Ltd..
